{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T22:43:53Z","timestamp":1793227433585,"version":"4.5.0"},"reference-count":60,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Gliomas, particularly glioblastoma (GBM), secrete abundant extracellular vesicles (EVs) that function as critical mediators of intercellular communication within the tumor microenvironment. These EVs carry diverse bioactive cargoes\u2014including immune checkpoint proteins, non-coding RNAs, metabolites, and metabolic regulators\u2014and can traverse the blood\u2013brain barrier, potentially through endothelial uptake, transcytosis, and glioma-associated barrier remodeling, thereby linking local and systemic immune regulation. This review summarizes current knowledge regarding the mechanisms by which glioma-derived EVs contribute to immunotherapeutic resistance. EV-associated programmed death-ligand 1 (PD-L1) directly engages PD-1 on T cells and may exert broader and more sustained immunosuppressive effects than tumor cell membrane-bound PD-L1 by enabling distal immune modulation and multivalent inhibitory signaling. Glioma-derived EVs also promote myeloid-derived suppressor cell expansion, drive tumor-associated macrophage and microglial polarization toward immunosuppressive phenotypes, impair dendritic cell-mediated antigen presentation, and collectively reinforce T-cell dysfunction. In addition, EV-enriched non-coding RNAs, such as miR-25-3p, miR-3591-3p, and lncRNA H19, regulate PI3K\u2013AKT\u2013mTOR, JAK2\/STAT3, and related pathways to promote myeloid reprogramming, immune escape, and temozolomide resistance. Importantly, EV-mediated temozolomide resistance and immunotherapeutic resistance may be interconnected through shared mechanisms involving non-coding RNA transfer, metabolic remodeling, inhibitory cytokine signaling, and myeloid-driven immune suppression. Furthermore, glioma EVs participate in tumor-specific immunometabolic regulation, including lipid, adenosine, amino acid, and glycolytic pathways, while exerting context-dependent effects on antigen presentation by either suppressing dendritic cell maturation or, under certain conditions, functioning as antigen carriers to stimulate antitumor immunity. Collectively, glioma-derived EVs act as central organizers of immune escape and therapeutic resistance. Targeting EV biogenesis, release, uptake, or specific immunosuppressive cargoes may provide promising opportunities to overcome resistance and improve immunotherapy for glioma. Future studies should focus on deciphering EV-mediated immune regulatory networks, identifying robust glioma-specific EV biomarkers, standardizing EV detection platforms, and developing precision EV-based therapeutic strategies.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1859282","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T06:09:08Z","timestamp":1779430148000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Glioma-derived extracellular vesicles as drivers of immunotherapeutic resistance: mechanisms of immune reprogramming and metabolic intervention"],"prefix":"10.3389","volume":"17","author":[{"given":"Jiaxin","family":"Wang","sequence":"first","affiliation":[{"name":"Affiliated Hospital of Liaoning University of Traditional Chinese Medicine","place":["Shenyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Peng","sequence":"additional","affiliation":[{"name":"Affiliated Hospital of Liaoning University of Traditional Chinese Medicine","place":["Shenyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Li","sequence":"additional","affiliation":[{"name":"Liaoning Cancer Hospital and Institute","place":["Shenyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianduo","family":"Wang","sequence":"additional","affiliation":[{"name":"Affiliated Hospital of Liaoning University of Traditional Chinese Medicine","place":["Shenyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-026-71021-x","article-title":"Developing a multimodal therapy for glioblastoma using oncolytic virus delivering CD19 and EGFRvIII antigens and bi-specific CARs","author":"Li","year":"2026","journal-title":"Nat Commun"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-026-08701-5","article-title":"Targeting the tumor microenvironment: reprogramming macrophages as a novel therapeutic strategy in FUOM-deficient glioblastoma","author":"Lu","year":"2026","journal-title":"Cell Death Dis"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1111\/cns.14239","article-title":"Exosomes-mediated crosstalk between glioma and immune cells in the tumor microenvironment","volume":"29","author":"Guo","year":"2023","journal-title":"CNS Neurosci Ther"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1021\/acsbiomaterials.5c00998","article-title":"GelMA hydrogel loading circNEFM-engineered exosomes inhibits glioma growth","volume":"11","author":"Fu","year":"2025","journal-title":"ACS Biomater Sci Eng"},{"key":"B5","article-title":"Liquid biopsy in central nervous system tumors: the potential roles of circulating miRNA and exosomes","volume":"10","author":"Aili","year":"2020","journal-title":"Am J Cancer Res"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2024.122743","article-title":"Exosomes: their role in the diagnosis, progression, metastasis, and treatment of glioblastoma","volume":"350","author":"Mousavikia","year":"2024","journal-title":"Life Sci"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e32376","article-title":"From bench to bedside: the promising value of exosomes in precision medicine for CNS tumors","volume":"10","author":"Wang","year":"2024","journal-title":"Heliyon"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252312524","article-title":"Glioma-derived exosomes and their application as drug nanoparticles","volume":"25","author":"Mastantuono","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B9","doi-asserted-by":"publisher","first-page":"FSO465","DOI":"10.2144\/fsoa-2019-0116","article-title":"Role of exosomes and exosomal microRNAs in cancer","volume":"6","author":"Dilsiz","year":"2020","journal-title":"Future Sci OA"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-021-06733-y","article-title":"Impact of native and external factors on exosome release: understanding reactive exosome secretion and its biogenesis","volume":"48","author":"Hariharan","year":"2021","journal-title":"Mol Biol Rep"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/cas.15433","article-title":"Nasopharyngeal cancer cell-derived exosomal PD-L1 inhibits CD8+ T-cell activity and promotes immune escape","volume":"113","author":"Yang","year":"2022","journal-title":"Cancer Sci"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2022.102454","article-title":"Exosomal B7-H4 from irradiated glioblastoma cells contributes to increase FoxP3 expression of differentiating Th1 cells and promotes tumor growth","volume":"56","author":"Tian","year":"2022","journal-title":"Redox Biol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1155\/2024\/1608582","article-title":"Exosomal PDL1 suppresses the anticancer activity of CD8+ T cells in hepatocellular carcinoma","volume":"2024","author":"Hu","year":"2024","journal-title":"Anal Cell Pathol (Amst)"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1644645","article-title":"Exosomal FABP5 drives HCC progression via macrophage lipid metabolism and immune microenvironment remodeling","volume":"16","author":"Luo","year":"2025","journal-title":"Front Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/9781683674023.ch100","article-title":"Exosome-mediated lectin pathway and resistin-MIF-AA metabolism axis drive immune dysfunction in immune thrombocytopenia","volume":"12","author":"Li","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/exp.20240039","article-title":"Engineered brain-targeting exosome for reprogramming immunosuppressive microenvironment of glioblastoma","volume":"5","author":"Yang","year":"2025","journal-title":"Explor (Beijing)"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.4c14573","article-title":"Glioblastoma cell derived exosomes as a potent vaccine platform targeting primary brain cancers and brain metastases","volume":"19","author":"Zou","year":"2025","journal-title":"ACS Nano"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.71792","article-title":"Decoding brain metastasis with liquid biopsy: biomarkers and technologies in EGFR-mutant NSCLC","volume":"15","author":"Sun","year":"2026","journal-title":"Cancer Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.bioactmat.2025.12.029","article-title":"Engineered small extracellular vesicles as bioactive materials: integrating engineering strategies for cargo loading and targeted delivery systems","volume":"59","author":"Xu","year":"2026","journal-title":"Bioact Mater"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/cph4.70128","article-title":"Look who is talking: extracellular vesicles as mediators of intercellular and interorgan communication","volume":"16","author":"Saviana","year":"2026","journal-title":"Compr Physiol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.17305\/bb.2026.13978","article-title":"Long non-coding RNAs in neurodegenerative diseases - molecular mechanisms, liquid biopsy biomarkers, and therapeutic targets: a review","author":"Cheng","year":"2026","journal-title":"Biomol BioMed"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1161\/circresaha.125.327357","article-title":"Mitochondria-derived vesicles and mitochondrial extracellular vesicles in health and cardiovascular disease","volume":"138","author":"Rapushi","year":"2026","journal-title":"Circ Res"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.128203","article-title":"Orchestrating tumor metastasis: exosomes as master regulators of the local and distant microenvironment","volume":"22","author":"Zhao","year":"2026","journal-title":"Int J Biol Sci"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2026.1697228","article-title":"Role of exosome therapy in reconstructive surgery: a review","volume":"13","author":"Arkoubi","year":"2026","journal-title":"Front Med (Lausanne)"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202504608","article-title":"Small extracellular vesicles from neural cells: physiological and pathological roles, and potential in neurodegenerative therapy","author":"Salim","year":"2026","journal-title":"Adv Healthc Mater"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-026-02093-y","article-title":"The role of small extracellular vesicles in ovarian cancer drug resistance: from bench clues to clinical implications","author":"Chen","year":"2026","journal-title":"J Ovarian Res"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3390\/cells9010096","article-title":"Extracellular vesicle-mediated communication between the glioblastoma and its microenvironment","volume":"9","author":"Matarredona","year":"2019","journal-title":"Cells"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.70002","article-title":"Hypoxic secretome and exosomes derived from human glioblastoma cells (U87MG) promote protumorigenic phenotype of microglia in vitro","volume":"126","author":"Pancholi","year":"2025","journal-title":"J Cell Biochem"},{"key":"B29","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s13577-025-01181-3","article-title":"Immunomodulatory role of exosome-derived content in pediatric medulloblastoma: a molecular subgroup perspective","volume":"38","author":"de Santis","year":"2025","journal-title":"Hum Cell"},{"key":"B30","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1186\/s12951-024-02888-5","article-title":"Hypoxic glioma-derived exosomal miR-25-3p promotes macrophage M2 polarization by activating the PI3K-AKT-mTOR signaling pathway","volume":"22","author":"Xue","year":"2024","journal-title":"J Nanobiotechnology"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3390\/ijms27052298","article-title":"Advancements in drug delivery systems in glioblastoma therapy","volume":"27","author":"Mishra","year":"2026","journal-title":"Int J Mol Sci"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1111\/pin.70099","article-title":"Astrocyte-glioblastoma stem cell interactions via extracellular vesicles contribute to distinct vascular structures","volume":"76","author":"Shirai","year":"2026","journal-title":"Pathol Int"},{"key":"B33","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s43556-026-00439-y","article-title":"Astrocytes in neuroinflammation and brain cancer","volume":"7","author":"Sun","year":"2026","journal-title":"Mol BioMed"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3390\/cells15030309","article-title":"Decoding glioblastoma through liquid biopsy: molecular insights and clinical prospects","volume":"15","author":"Wasiak","year":"2026","journal-title":"Cells"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.70268","article-title":"Extracellular vesicle-mediated nucleolin transfer in glioblastoma: a targetable axis driving blood-tumour barrier formation","volume":"15","author":"Chen","year":"2026","journal-title":"J Extracell Vesicles"},{"key":"B36","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1007\/s12032-025-03216-z","article-title":"Extracellular vesicles-mediated communication between glioblastoma and astrocytes promotes pro-tumorigenic activation","volume":"43","author":"Taskan","year":"2026","journal-title":"Med Oncol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1007\/s11033-026-11526-2","article-title":"Glioblastoma exosomes reprogramming the tumor microenvironment and evading therapeutic challenges","volume":"53","author":"Tatode","year":"2026","journal-title":"Mol Biol Rep"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adt2804","article-title":"Monitoring glioblastoma extracellular vesicle evolution using a nanodiagnostic platform to detect glioma stem cells driving recurrent disease","volume":"12","author":"Zhang","year":"2026","journal-title":"Sci Adv"},{"key":"B39","doi-asserted-by":"publisher","first-page":"2026.03.03.706465","DOI":"10.64898\/2026.03.03.706465","article-title":"Macrophage-derived extracellular vesicles promote T cell-dependent inflammatory pain resolution","author":"Wickman","year":"2026","journal-title":"bioRxiv"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.6275","article-title":"Prostate cancer cells synergistically defend against CD8+ T cells by secreting exosomal PD-L1","volume":"12","author":"Li","year":"2023","journal-title":"Cancer Med"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1080\/08830185.2026.2631464","article-title":"Understanding the role of regulatory T cell-derived small extracellular vesicles in suppression of anti-tumor immune response: key to advancing cancer immunotherapy","volume":"12","author":"Seth","year":"2026","journal-title":"Int Rev Immunol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/s41419-026-08523-5","article-title":"Sphingosine-1-phosphate promotes CD8 T cell exhaustion in breast cancer via exosomal transfer of TGFBR2","volume":"17","author":"Bhoumick","year":"2026","journal-title":"Cell Death Dis"},{"key":"B43","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s11033-023-09196-5","article-title":"Tumor-derived extracellular vesicles: how they mediate glioma immunosuppression","volume":"51","author":"Ma","year":"2024","journal-title":"Mol Biol Rep"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-022-02457-w","article-title":"Tumor-derived exosomes deliver the tumor suppressor miR-3591-3p to induce M2 macrophage polarization and promote glioma progression","volume":"41","author":"Li","year":"2022","journal-title":"Oncogene"},{"key":"B45","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s12032-022-01837-2","article-title":"Extracellular vesicle-based checkpoint regulation and immune state in cancer","volume":"39","author":"Mortezaee","year":"2022","journal-title":"Med Oncol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1186\/s12951-026-04223-6","article-title":"Visualizing extracellular vesicles in cancer: from biogenesis to theranostic applications","volume":"24","author":"Deng","year":"2026","journal-title":"J Nanobiotechnology"},{"key":"B47","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1038\/s41419-020-03042-3","article-title":"Exosomal LGALS9 in the cerebrospinal fluid of glioblastoma patients suppressed dendritic cell antigen presentation and cytotoxic T-cell immunity","volume":"11","author":"Wang","year":"2020","journal-title":"Cell Death Dis"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1111\/cns.14643","article-title":"Exosome-transmitted podoplanin promotes tumor-associated macrophage-mediated immune tolerance in glioblastoma","volume":"30","author":"Wu","year":"2024","journal-title":"CNS Neurosci Ther"},{"key":"B49","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1186\/s12943-026-02645-2","article-title":"The pre-metastatic niche: mechanisms, heterogeneity, and therapeutic opportunities","volume":"11","author":"Zhang","year":"2026","journal-title":"Mol Cancer"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1748272","article-title":"The dual roles of exosomes in prostate cancer: mechanisms in tumorigenesis and avenues for clinical translation","volume":"17","author":"Yu","year":"2026","journal-title":"Front Immunol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.2147\/ijn.s587735","article-title":"Polarization-specific macrophage-derived extracellular vesicles: Molecular cargo, tumor microenvironment remodeling, and therapeutic opportunities","volume":"21","author":"Liu","year":"2026","journal-title":"Int J Nanomedicine"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2026.111364","article-title":"Ion channel and biophysical properties of extracellular vesicles","volume":"302","author":"Sanghvi","year":"2026","journal-title":"J Biol Chem"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.2147\/ijn.s589123","article-title":"The dual role of extracellular vesicles in aging and age-related diseases: Pathophysiology and therapeutic potential","volume":"21","author":"Zhu","year":"2026","journal-title":"Int J Nanomedicine"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajps.2025.101065","article-title":"Extracellular vesicles in cancer immunotherapy: Therapeutic, challenges and clinical progress","volume":"20","author":"Manoochehri","year":"2025","journal-title":"Asian J Pharm Sci"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.215630","article-title":"Exosomal microRNAs induce tumor-associated macrophages via PPAR\u03b3 during tumor progression in SHH medulloblastoma","volume":"535","author":"Zhu","year":"2022","journal-title":"Cancer Lett"},{"key":"B56","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41419-022-04534-0","article-title":"Tumor-associated macrophages promote cholangiocarcinoma progression via exosomal Circ_0020256","volume":"13","author":"Chen","year":"2022","journal-title":"Cell Death Dis"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112406","article-title":"Tumor-associated macrophages derived exosomes; from pathogenesis to therapeutic opportunities","volume":"136","author":"Hadad","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1186\/s12951-026-04176-w","article-title":"Exosome-enabled bone defect repair: mechanistic foundations, bioengineered delivery, and artificial intelligence-driven translation","volume":"24","author":"Yang","year":"2026","journal-title":"J Nanobiotechnology"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.2147\/ijn.s583756","article-title":"Exosomes as pivotal mediators of tumor-immune communication: Implications for immunotherapy and liquid biopsy","volume":"21","author":"Wei","year":"2026","journal-title":"Int J Nanomedicine"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202521802","article-title":"Extracellular vesicles in autoimmune diseases: From diagnostic biomarkers to engineered therapeutics","volume":"13","author":"Wu","year":"2026","journal-title":"Adv Sci (Weinh)"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1859282\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T06:09:13Z","timestamp":1779430153000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1859282\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,22]]},"references-count":60,"alternative-id":["10.3389\/fimmu.2026.1859282"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1859282","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,22]]},"article-number":"1859282"}}